Celebrities

Katie Price’s son Harvey sheds 12 pounds fast—Mounjaro fuels shock

By GoNews Pulse Editorial Team••Updated Oct 6, 2026
Share
Katie Price’s son Harvey sheds 12 pounds fast—Mounjaro fuels shock

**Katie Price’s 24‑Year‑Old Son Harvey Begins Weight‑Loss Treatment, Loses Two Stone**

Katie Price announced that her eldest son Harvey, 24, has shed two stone after starting the weight‑loss injection Mounjaro. The former model said the change came after months of worry about Harvey’s health and a series of medical interventions.

Harvey was born with Prader‑Willi syndrome, a condition that causes an insatiable appetite and chronic hunger. He also struggles with autism, septo‑optic dysplasia, ADHD and oppositional defiant disorder. At the start of 2025 his weight had climbed to nearly 30 stone.

In April that year, adjustments to his diet helped him lose 1½ stone, but the medical team remained concerned about his obesity.

The latest update came during a podcast episode with Price’s sister Sophie. “And yeah he’s started Mounjaro because I told you he’s lost two stone,” she said. “I can really see him losing weight.” The injection, approved for weight control, has now begun to produce visible results.

## Background & Context

Prader‑Willi syndrome is a genetic disorder that triggers relentless hunger and often leads to obesity. Because of his weight, Harvey’s doctors have warned that he is at high risk for heart disease. In a 2024 interview, Price expressed the fear that he could “end up dying of a heart attack” if his weight didn’t fall.

Earlier this year, Price revealed that she had pleaded with doctors to place Harvey on Mounjaro. She explained that the NHS was “so much… they know he’s in the obese category.” In November, doctors said they were ready to give him a new weight‑loss drug once it finished clinical trials, but only after he tried diet first.

Price said the new drug would work faster if he began with Mounjaro.

For months she had been “on the case to doctors about putting him on the Mounjaro,” and she even threatened to post on Instagram asking private doctors for help, . She added that she would not self‑inject him because that was “not medically right.”

## What People Are Saying

During her recent podcast, Price highlighted the progress of Harvey’s treatment. “And I can really see him losing weight,” she noted, underscoring the visual change. The weight loss has been quantified as two stone since the start of the injections.

Price also reflected on earlier fears when her son’s snoring and wheezing during sleep began to alarm her. “When he sleeps, I worry because he’s snoring and wheezing… I’m like he’s massive,” she explained.

Her concerns were echoed by doctors who warned that continued obesity could trigger a heart attack.

In the same conversation, Price admitted that she feels “so bad” and remains determined to help Harvey, but clarified that she cannot administer injections herself. Instead, she is awaiting medical approval for Mounjaro.

## What Happens Next

Harvey’s current weight is 28 stone; with the two‑stone loss, he now stands at 26 stone. The injection regimen is ongoing, and Price expects continued progress as the treatment takes effect.

No official timeline has been released for the next phase of therapy, but Price indicated that a new weight‑loss drug could be considered once the current injections are fully evaluated.

The family plans to monitor Harvey’s response closely, especially regarding his breathing issues at night. If the weight loss continues, doctors may reassess the risk of heart disease and adjust his treatment plan accordingly.

In the coming months, Price will likely provide further updates on her podcast or through other public channels. She has already expressed gratitude for medical support and will keep the family’s health journey in the spotlight.

Why It Matters

The story of Katie Price’s son Harvey gaining weight through a rare genetic condition and now losing two stone with the injection Mounjaro is significant on multiple fronts. First, it brings public attention to Prader‑Willi syndrome, a disorder that often leads to severe obesity and associated health risks such as heart disease. By showcasing a tangible improvement in a 24‑year‑old patient, the article highlights the potential of newer pharmacological interventions for a condition that historically had limited treatment options. Second, the narrative underscores the role of celebrity advocacy in influencing medical discourse and patient access. Katie Price’s outspoken campaign against NHS delays and her willingness to share the journey publicly may pressure healthcare providers to adopt more timely treatments for similar patients. Third, the piece resonates with broader conversations around obesity management, especially the growing reliance on medication like Mounjaro, which is originally approved for type 2 diabetes but has shown promising weight‑loss effects. Fans and health professionals alike are watching how this case may inform policy and best practices for rare‑disease weight management, potentially prompting earlier drug approvals and better insurance coverage. Overall, the article serves as a case study in patient advocacy, medical innovation, and the intersection of celebrity influence with public health.

Our Take

While Katie Price’s public disclosure of her son Harvey’s weight loss journey is commendable and offers hope for families dealing with Prader‑Willi syndrome, it also raises important questions about the accessibility of cutting‑edge treatments. The story underscores how celebrity momentum can fast‑track medication approvals and bring attention to under‑funded conditions, yet it also reminds us that many patients still face bureaucratic hurdles and financial barriers. Mounjaro’s promising results in a single case should not be taken as a blanket solution; rigorous clinical trials remain essential before widespread recommendation. the narrative should encourage health systems to streamline pathways for rare‑disease treatments, reducing wait times and ensuring equitable access. In the meantime, Price’s candid sharing is a powerful reminder that personal advocacy can catalyse change, but it must be paired with structural reforms that make advanced therapies available to all who need them.

GoNews Pulse Editorial Team

This article was prepared for publication by GoNews Pulse and checked for publication requirements under our editorial standards. We review available information and correct material errors when they are identified.

Quick Answers

What is the latest update on this story?
He’s shedding 12 pounds with Mounjaro—find out what’s driving the viral conversation around his new look.
Who is this story about?
This article covers developments related to Katie Price’s son Harvey sheds 12 pounds fast—Mounjaro fuels shock. GoNews Pulse's editorial team monitors the story and updates the article as new verified information becomes available.
Where can I read more about Katie Price?
GoNews Pulse publishes original reporting on Katie Price and related entertainment news. Visit the homepage or browse the section dedicated to this story for the latest coverage.

Related topics

  • #Katie Price
  • #Harvey Price
  • #Mounjaro
  • #weight loss injection

More From This Section